MedPath

5'-S-methyl-5'-thioadenosine

Generic Name
5'-S-methyl-5'-thioadenosine
Drug Type
Small Molecule
Chemical Formula
C11H15N5O3S
CAS Number
2457-80-9
Unique Ingredient Identifier
634Z2VK3UQ
Clinical Trials
Related News

Clinical and Radiographic Evaluation of Laser Photobiomodulation Pulpotomy of Primary Molars in Children

Not Applicable
Recruiting
Conditions
Pulpitis
Pulpotomy
Interventions
Device: Photobiomodulation
First Posted Date
2023-05-09
Last Posted Date
2023-05-09
Lead Sponsor
Aliaa Hamouda
Target Recruit Count
52
Registration Number
NCT05850780
Locations
🇪🇬

Faculty of Dentistry, Alexandria University, Alexandria, Egypt

TheraCal LC Coronal Pulpotomy and MTA Coronal Pulpotomy in Mature Permanent Molars

Phase 4
Active, not recruiting
Conditions
Irreversible Pulpitis
Deep Caries
Interventions
Drug: Theracal LC
First Posted Date
2023-02-17
Last Posted Date
2023-02-17
Lead Sponsor
Postgraduate Institute of Dental Sciences Rohtak
Target Recruit Count
72
Registration Number
NCT05733468
Locations
🇮🇳

POST GRADUATE INSTITUTE OF DENTAL SCIENCES Rohtak, Rohtak, Haryana, India

Clinical Assessment of 3 Differant Obturation Sealers on Postoprative Pain and Swelling

Phase 2
Conditions
Single Root Teeth
Necrotic Pulp
Interventions
Drug: bioceramic sealer
First Posted Date
2022-06-15
Last Posted Date
2022-06-15
Lead Sponsor
Cairo University
Target Recruit Count
60
Registration Number
NCT05419752

Partial Versus Complete Pulpotomy Using Three Different Materials in Primary Molars: a Clinical Study

Phase 4
Completed
Conditions
Decayed Primary Molars
Interventions
Drug: TheraCal
Drug: Formocresol
Procedure: pulpotomy
Procedure: partial pulpotomy
First Posted Date
2022-01-13
Last Posted Date
2022-01-18
Lead Sponsor
Mansoura University
Target Recruit Count
60
Registration Number
NCT05190783
Locations
🇪🇬

Mansoura University, Mansoura, Dakahlia, Egypt

Efficacy of Totalfill® and ProRoot MTA® as Pulpotomy Agent in Primary Molars

Phase 4
Completed
Conditions
Extensively Decayed Primary Molars
Interventions
Drug: Totalfill
First Posted Date
2021-12-08
Last Posted Date
2023-11-22
Lead Sponsor
University Ghent
Target Recruit Count
36
Registration Number
NCT05149651
Locations
🇧🇪

Ghent University hospital, Ghent, Belgium

Indirect Pulp Treatment in Primary Teeth

Not Applicable
Conditions
Deep Caries
Interventions
First Posted Date
2021-02-21
Last Posted Date
2021-02-21
Lead Sponsor
Cairo University
Target Recruit Count
88
Registration Number
NCT04763057

Survival Rate After TheraCal PT Pulpotomy Versus MTA Pulpotomy in Children With Vital Primary Molars.

Not Applicable
Conditions
Reversible Pulpitis
Interventions
Drug: TheraCal PT
First Posted Date
2020-11-05
Last Posted Date
2022-03-04
Lead Sponsor
Cairo University
Target Recruit Count
20
Registration Number
NCT04617600

Evaluation of Chitosan Scaffold and Mineral Trioxide Aggregate Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis

Phase 2
Completed
Conditions
Pulpitis - Irreversible
Interventions
Drug: Chitosan scaffold/ MTA pulp dressing material
First Posted Date
2020-03-16
Last Posted Date
2022-05-19
Lead Sponsor
Nourhan M.Aly
Target Recruit Count
30
Registration Number
NCT04308863
Locations
🇪🇬

Faculty of Dentistry, Alexandria University, Alexandria, Egypt

Prospective Clinical Trial of Three Apical Sealing Materials

Phase 4
Completed
Conditions
Periapical Abscess
Interventions
Drug: Biodentine
Drug: EndoSequence
First Posted Date
2019-12-13
Last Posted Date
2019-12-13
Lead Sponsor
University of the Pacific
Target Recruit Count
59
Registration Number
NCT04198298

Evaluation the Effect of Using of Apical Matrix With Apexification Procedure on Apical Healing of Necrotic Immature Teeth

Phase 2
Completed
Conditions
Pulp Necrosis
Apexification
Interventions
Procedure: Apexification
Drug: Ca(OH)2
Drug: Apical matrix
First Posted Date
2019-02-21
Last Posted Date
2019-02-21
Lead Sponsor
Al-Azhar University
Target Recruit Count
32
Registration Number
NCT03849222
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy